Delivery Order SPE2DB20D2104-SPE2DB25FMNEY

Award Date 4/10/25
Potential Completion Date 4/11/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,809.18 firm-fixed-price contract is for the supply of Mounjaro 10 mg/0.5 ml pens, a medication used to treat diabetes. The delivery order is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This IDC enables...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Mounjaro 12.5 mg/0.5 ml pens, a medication used to treat diabetes. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $4,165.98 and a period of performance through May 5, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Mounjaro 5 mg/0.5 ml pens, a diabetes medication. The fixed-price delivery order has a ceiling value of $1,574.85 and a completion date of May 7, 2025. This award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Mounjaro 7.5 mg/0.5 ml pens, a medication used to treat diabetes. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $1,088.36 and a period of performance through April 11, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mounjaro 15 mg/0.5 ml pens, a medication used to treat diabetes. The contract has a ceiling value of $1,632.54 and is a firm fixed price, non-set-aside delivery order with a performance period ending on May 8, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,360.07 contract is for the supply of Mounjaro 2.5 mg/0.5 mL pens, a medication used to treat diabetes. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a comprehensive global...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the diabetes medication Mounjaro (7.5 mg/0.5 ml pen). The contract has a firm fixed price of $1,088.36 and a performance period ending on April 10, 2025. The award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999.00. This...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,493.58, is for the supply of Mounjaro 10 mg/0.5 ml pens, a medication used to treat diabetes. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Mounjaro 10 mg/0.5 ml pens, a diabetes medication. The contract has a ceiling value of $3,011.39 and a performance period ending on April 29, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Mounjaro, a 15 mg/0.5 mL diabetes medication pen, with a ceiling value of $3,117.61 and a period of performance through April 16, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMNEY
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Mounjaro 10 mg/0.5 ml pens, a diabetes medication, with a ceiling value of $1,729.00 and a period of performance through April 11, 2025.

The award is not set aside and represents a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00. This IDC provides a comprehensive global pharmaceutical support vehicle for the Defense Health Agency, U.S. Coast Guard, and other government agencies, enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military and veteran healthcare programs.

Generated 7/17/25, 6:09 PM